Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 5, 2025, 4:00 PM EST
1.080
-0.010 (-0.92%)
After-hours: Dec 5, 2025, 7:59 PM EST
Company Description
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia.
It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Gelteq Limited
| Country | Australia |
| Founded | 2018 |
| IPO Date | Oct 29, 2024 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Nathan Givoni |
Contact Details
Address: Monash Innovation Labs, G.60, 22 Alliance Lane Clayton, VIC 3800 Australia | |
| Phone | 61 3 9087 3990 |
| Website | gelteq.com |
Stock Details
| Ticker Symbol | GELS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| IPO Price | $4.00 |
| CIK Code | 0001920092 |
| ISIN Number | AU0000218109 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nathan Jacob Givoni | Co-Founder, Chief Executive Officer and Executive Director |
| Simon Hayden Szewach | Co-Founder and Non-Executive Chairman |
| Thuy-Linh Gigler | Chief Financial Officer |
| Dr. Paul M. Wynne Ph.D. | Chief Scientific Officer |
| Adam Bendell | President of U.S. Operations |
| Matthew Jones | Head of Sports Performance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 17, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Nov 3, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Aug 29, 2025 | EFFECT | Notice of Effectiveness |
| Aug 29, 2025 | 424B3 | Prospectus |
| Jul 25, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jul 8, 2025 | UPLOAD | Filing |
| Jul 1, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Jun 30, 2025 | 6-K | Report of foreign issuer |
| Mar 14, 2025 | 6-K | Report of foreign issuer |
| Nov 15, 2024 | 20-F | Annual and transition report of foreign private issuers |